Chengyi Li
机构:Qinghai University, Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Johns Hopkins University, Chongqing University, Hohai University, Chongqing University of Science and Technology, University of Michigan, Fred Hutch Cancer Center, Gansu University of Traditional Chinese Medicine, Michigan Cancer Research Consortium, Huaiyin Institute of Technology, Chongqing Jiaotong University · ORCID:0000-0003-2378-6408
发表论文 142 篇 · 总被引 2004 次 · h-index 25
代表论文
- MiR-21-3p inhibitor exerts myocardial protective effects by altering macrophage polarization state and reducing excessive mitophagy (2024 · Communications Biology · 被引 25)
- Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk (2024 · ACS Nano · 被引 22)
- SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation (2025 · ACS Nano · 被引 8)
- Study on seismic performance of steel frame beam-slab-column joint based on angle unilateral connection (2025 · Engineering Structures · 被引 8)
- Asclepius: A Spectrum Evaluation Benchmark for Medical Multi-Modal Large Language Models (2025 · 被引 7)
- Efficacy and safety of Qingfei Huatan formula in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A multi-centre, randomised, double-blind, placebo-controlled trial (2024 · Journal of Chinese Integrative Medicine · 被引 5)